{{Drugbox
| IUPAC_name = 4-(3-{3-[4-(4-fluorobenzoyl)-1-piperidinyl]propoxy}-4-methoxyphenyl)-2-pyrrolidinone
| image = Lidanserin_structure.png
| width = 240
| CAS_number = 73725-85-6
| CAS_supplemental = 
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 68919
| ChemSpiderID = 62146
| C=26 | H=31 | F=1 | N=2 | O=4
| molecular_weight = 454.534 g/mol
| smiles = Fc1ccc(cc1)C(=O)C4CCN(CCCOc2cc(ccc2OC)C3CC(=O)NC3)CC4
| StdInChI = 1S/C26H31FN2O4/c1-32-23-8-5-20(21-16-25(30)28-17-21)15-24(23)33-14-2-11-29-12-9-19(10-13-29)26(31)18-3-6-22(27)7-4-18/h3-8,15,19,21H,2,9-14,16-17H2,1H3,(H,28,30)
| StdInChIKey = JDYWZVJXSMADHP-UHFFFAOYSA-N
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 
}}

'''Lidanserin''' ([[International Nonproprietary Name|INN]]; '''ZK-33,839''') is a [[drug]] which acts as a combined [[5-HT2A receptor|5-HT<sub>2A</sub>]] and [[α1-adrenergic receptor|α<sub>1</sub>-adrenergic receptor]] [[receptor antagonist|antagonist]].<ref name="Allen1989">{{cite book | author = Richard C. Allen | title = Annual Reports in Medicinal Chemistry | url = https://books.google.com/books?id=HrALiG-4t7UC&pg=PA56 | accessdate = 6 May 2012 | year = 1989 | publisher = Academic Press | isbn = 978-0-12-040524-4 | page = 56}}</ref><ref name="SocietyService1989">{{cite book | author1 = American Chemical Society | author2 = American Chemical Society. Chemical Abstracts Service | title = Chemical abstracts | url = https://books.google.com/books?id=WkEcAQAAMAAJ | accessdate = 6 May 2012 | date = 27 February 1989 | publisher = American Chemical Society | page= 114}}</ref> It was developed as an [[antihypertensive agent]] but was never marketed.<ref name="Allen1989" /><ref name="SocietyService1989" />

== See also ==
* [[Ketanserin]]

== References ==
{{Reflist}}

{{Antihypertensives}}
{{Adrenergics}}
{{Serotonergics}}

[[Category:5-HT2A antagonists]]
[[Category:Abandoned drugs]]
[[Category:Alpha blockers]]
[[Category:Antihypertensive agents]]
[[Category:Ketones]]
[[Category:Fluoroarenes]]
[[Category:Piperidines]]
[[Category:Pyrrolidones]]

{{nervous-system-drug-stub}}